A r t i c l e s Acetylcholine (ACh), the first identified neurotransmitter, mediates cell-to-cell communication in the central and peripheral nervous systems, as well as non-neuronal systems [1] [2] [3] [4] [5] [6] [7] . Cholinergic projection neurons within the mammalian brain originate primarily in three major nuclei, including the basal forebrain, the brainstem pedunculopontine, and laterodorsal tegmental nuclei in the brainstem. Cholinergic neurons within these groups project widely throughout the cortical and subcortical domains, consistent with their involvement in complex brain functions, including attention, perception, associative learning, and sleep/awake balancing 1-5 . Additional smaller populations of cholinergic neurons scatter throughout other brain areas (e.g., the medial habenula (MHb) and the striatum), contributing to behaviors related to motion, motivation, and stress 1,3,8 . Dysregulation of central cholinergic transmission is linked to a number of brain disorders, including Alzheimer's disease, addiction, epilepsy, Parkinson's disease, schizophrenia, and depression 9,10 . In the peripheral nervous and nonnervous systems, ACh is released by both neurons and non-neuronal cells to relay fast transmission at neuromuscular junctions and to regulate functions of a variety of other tissues and organs, including the heart, liver, and pancreas 5-7 . Dysregulation of peripheral and nonneuronal cholinergic signals is associated with multiple pathological states, including cardiovascular disease, diabetes, immune deficiency, and cancer 11, 12 .
The neurotransmitter acetylcholine (ACh) regulates a diverse array of physiological processes throughout the body. Despite its importance, cholinergic transmission in the majority of tissues and organs remains poorly understood owing primarily to the limitations of available ACh-monitoring techniques. We developed a family of ACh sensors (GACh) based on G-protein-coupled receptors that has the sensitivity, specificity, signal-to-noise ratio, kinetics and photostability suitable for monitoring ACh signals in vitro and in vivo. GACh sensors were validated with transfection, viral and/or transgenic expression in a dozen types of neuronal and non-neuronal cells prepared from multiple animal species. In all preparations, GACh sensors selectively responded to exogenous and/or endogenous ACh with robust fluorescence signals that were captured by epifluorescence, confocal, and/or two-photon microscopy. Moreover, analysis of endogenous ACh release revealed firing-pattern-dependent release and restricted volume transmission, resolving two long-standing questions about central cholinergic transmission. Thus, GACh sensors provide a user-friendly, broadly applicable tool for monitoring cholinergic transmission underlying diverse biological processes.
RESULTS

Development and optimization of GACh sensors
We first inserted a conformationally sensitive cpGFP into the third intracellular loop (ICL 3 ) of five subtypes of human muscarinic acetylcholine receptors (M 1-5 Rs) ( Fig. 1a and Supplementary Fig. 1) . ICL 3 was chosen because it links the transmembrane helices 5 and 6 of MRs and may undergo a large conformational change upon ACh binding 22 . We replaced ICL 3 of M [1] [2] [3] [4] [5] Rs with a shorter 54-amino acid ICL 3 modified from the structurally well-characterized β 2 adrenergic receptor (β 2 AR) 23 to avoid creating a lengthy cpGFP-containing ICL 3 that may hinder the expression and trafficking of the proteins (Supplementary Fig. 1a) . Cells expressing the M 3 R chimera showed excellent membrane expression in HEK293T cells and increased fluorescence responses (∆F/F 0 ) (by ~30%) to bath application of ACh ( Fig. 1b and Supplementary Fig. 1a) . In contrast, cells expressing the other four MR chimeras all exhibited poor membrane expression and no detectable ∆F/F 0 upon ACh application ( Supplementary Fig. 1b-d) .
To improve this new ACh sensor (named GACh1.0), we used site-directed mutagenesis to create a library of 723 randomized point mutations at the N terminus two-amino acid and C terminus five-amino acid linkers that connect cpGFP and M 3 R ( Fig. 1c and Supplementary Fig. 2 ). When expressed in HEK293T cells, we found variants with one or multiple single-point mutations on the seven linker residues (total 18 hits) produced relatively larger ∆F/F 0 responses, with the best variant (named GACh1.5) producing a ~70% increase in ∆F/F 0 (Fig. 1c,d and Supplementary Fig. 2) . In a second round of site-directed mutagenesis and screening, we used combinations of single top hits on N terminus linker residues (i.e., GG) and two to four top hits on C terminus linker residues, and found one variant (named GACh2.0) out of 23 combinatorial variants with the best ∆F/F 0 ( Fig. 1c and Supplementary Fig. 2 ). GACh2.0 had the same expression and membrane trafficking properties and enhanced dynamic range (by 2.5-fold) compared to GACh1.0 ( Fig. 1e-g and Supplementary Movie 1), and ~20-fold larger peak signal responses and ~60-fold higher signal-to-noise ratio (SNR) compared to M 1 Rbased FRET sensor 18 (Fig. 1h-j and Supplementary Fig. 3 ).
Characterization of GACh sensors in cultured cells
Next, we measured the response kinetics of GACh2.0 ( Fig. 2a,b) . High-speed imaging showed that rapid local perfusion of agonist ACh or antagonist tiotropium (Tio) elicited increases or decreases in fluorescence intensity of GACh2.0, with average activation (on) and inactivation (off) time constants of 280 ± 32 ms and 762 ± 75 ms, respectively (Fig. 2b,c) . These values were likely overestimated due to the slow drug application/perfusion system (~80 ms delay, Supplementary Fig. 4) . Moreover, confocal imaging indicated that GACh sensors had a photostability comparable to or better than GCaMP6s and EGFP (Supplementary Fig. 5 ). Altering extracellular pH with buffers (pH 5-9) resulted in modest fluorescence changes in GACh-expressing cells (Supplementary Fig. 6a,b ), suggesting a weak pH dependency. In the permeabilized condition, the fluorescence of GACh sensors exhibited larger pH dependency with a pK a close to 7 (Supplementary Fig. 6c,d) .
To measure the sensitivity of GACh2.0, we progressively increased ACh from 10 nM to 100 µM, which increased the fluorescence intensity in GACh2.0-expressing cells, yielding an EC 50 (concentration for 50% maximal effect) of ~0.7 µM (Fig. 2d,e ), a value comparable to wild-type M 3 Rs 24 . ACh-induced fluorescence signals were completely blocked by co-application of 20 µM AF-DX 384, another muscarinic antagonist 25 , indicating specific responses. We also characterized the downstream signaling of GACh sensors. GACh2.0-expressing cells exhibited less receptor internalization in the presence of ACh, as well as reduced TANGO assay signal (β-arrestin-dependent) compared to wild-type M 3 Rs-expressing cells ( Supplementary Fig. 7a,b) . Moreover, the coupling efficiency from GACh2.0 to the Gq-dependent calcium signaling was about sevenfold smaller compared to wild-type M 3 Rs ( Supplementary Fig. 7c-e ), and there was no detectable coupling of GACh2.0 to the Gs-dependent signaling pathway ( Supplementary Fig. 7f-h) .
We next verified several properties of GACh sensors in cultured rat cortical neurons ( Fig. 2f-j) . Approximately 48 h after transfection, GACh1.0 and GACh2.0 were expressed throughout the neuronal membrane, with the majority of sensors delivered to the neurites (Fig. 2f) . ACh enhanced the fluorescence intensity of GACh1.0 and GACh2.0 by ~30% and ~90%, respectively ( Fig. 2g and Supplementary Movie 2), validating their functionality in neurons. Varying ACh concentration in the bath solution from 10 nM to 100 µM progressively increased the fluorescence intensity in GACh2.0-expressing neurons, with an EC 50 of ~2 µM (Fig. 2h) . In contrast, bath application of nicotine, choline, glycine, serotonin (5-HT), epinephrine, GABA, glutamate, dopamine, norepinephrine, histamine, and adenosine did not induce any detectable fluorescence responses. Moreover, ACh-induced fluorescence responses were blocked by bath-applied Tio (Fig. 2i,j) . Finally, we noted no alteration in membrane fluorescence intensity in GACh2.0 -expressing neurons during a 30-min bath application of 100 µM ACh (Supplementary Fig. 8a-c) , consistent with the minimal arrestindependent internalization ( Supplementary Fig. 7a,b) .
Validation of GACh sensors in cultured brain slices
To generalize the applicability of GACh sensors, we expressed them in CA1 pyramidal neurons in cultured mouse hippocampal slices. Twophoton imaging showed that GACh1.0, GACh1.5, and GACh2.0 were expressed throughout CA1 pyramidal neurons by the lentiviral system, with evident fluorescence signals at the plasma membrane of somata, dendrites, and spines, sites of excitatory synapses (Supplementary Fig. 9 ). Next, we chose the Sindbis viral expression system that permitted a more rapid (~18 h) and robust expression of GACh sensors ( Supplementary  Figs. 10a and 11a) . Fluorescence responses captured by an epifluorescence microscope showed that a brief 500-ms puff application of ACh or the muscarinic agonist oxotremorine 24 evoked fluorescence responses in CA1 neurons expressing GACh1.0, GACh1.5, or GACh2.0, whereas puff application of a nicotinic receptor agonist, nicotine, or control bath solution ACSF induced no responses in same neurons ( Supplementary  Figs. 10b-d and 11b and Supplementary Movies 3 and 4) . 24.6 ± 1.5%, n = 19 cells from five cultures, GACh2.0: 90.1 ± 1.7%, n = 29 cells from eight cultures, U = 551, P = 6.72 × 10 -9 ). (h) Fluorescence responses of HEK293T cells expressing either GACh2.0 or M 1 R-based FRET sensor to the application of ACh (100 µM). (i,j) Averaged ∆F/F 0 or ∆FRET ratio (GACh2.0: 94.0 ± 3.0%, n = 10 cells from two cultures; FRET: 6.61 ± 0.4%, n = 10 cells from two cultures, U = 100, P = 1.09 × 10 -5 ) and SNR (GACh2.0: 60.0 ± 5.4, n = 10 cells from two cultures; FRET: 1.12 ± 0.21, n = 10 cells from two cultures, U = 100, P = 1.83 × 10 -4 ) of GACh2.0 and M 1 R-based FRET-sensor-expressing cells to ACh application. Data are shown as mean ± s.e.m., with error bars indicating s.e.m. Experiments in b and e were repeated independently for more than five cultures with similar results. ***P < 0.001 (Mann-Whitney Rank Sum non-parametric tests, two-sided). All scale bars, 10 µm.
Focusing on GACh2.0, which produces the largest ∆F/F 0 , we found that repetitive puffs induced the same fluorescence responses in GACh2.0-expressing CA1 neurons ( Supplementary Fig. 12 ), indicating robust photostability. As a control, bath application of 1 µM atropine, a muscarinic antagonist 25 , but not 2,2,6,6-tetramethylpiperidin-4-yl heptanoate (TMPH), a nicotinic antagonist 26 blocked ACh-induced fluorescence responses in GACh2.0-expressing neurons ( Supplementary Fig. 12 ). Simultaneous patch-clamp recordings showed that the resting membrane potential, input resistance, membrane time constant and average spiking frequency of GACh2.0-expressing CA1 neurons were not different from nearby control non-expressing neurons ( Supplementary Fig. 13a-d) , suggesting GACh2.0 expression had no effect on basic membrane properties. Moreover, AMPA, NMDA, and GABAergic responses, as well as paired pulse facilitation of AMPA responses in GACh2.0-expressing neurons, remained unchanged ( Supplementary Fig. 13e-h) , indicating GACh2.0 expression did not alter synaptic transmission. Collectively, these results are consistent with the finding that GACh2.0 is a selective, photostable ACh sensor with minimal perturbation on cellular physiology.
To compare GACh2.0 imaging with patch-clamp recordings, we simultaneously made whole-cell recordings and fluorescence imaging from pairs of neighboring GACh2.0-expressing and nonexpressing CA3 pyramidal neurons, which performed robust current response to cholinergic stimulation in cultured mouse hippocampal slices 27 (Fig. 3a) . A 500-ms ACh puff evoked a brief, large inward current followed by a prolonged, small inward current in both GACh2.0-expressing and non-expressing neurons, presumably representing activation of endogenous nicotinic and muscarinic receptors, respectively 3 (Fig. 3b,d) . A concurrent fluorescence signal was observed only in GACh2.0-expressing neurons, but not in control non-expressing CA3 neurons (Fig. 3b,c) . The latencies of cholinergic currents and fluorescence responses were the same in GACh2.0expressing neurons (Fig. 3b,e ), indicating that GACh2.0 detected ACh as fast as endogenous cholinergic receptors. SNR of GACh2.0 fluorescence responses (~14) seemed to be smaller than that of the fast nicotinic-like cholinergic currents (~35), but larger than that of the slow muscarinic-like cholinergic currents (~8) (Fig. 3b,f) , indicating a relatively comparable sensitivity for GACh2.0 to electrophysiological recording in monitoring cholinergic signals. The second ACh puff evoked same fluorescence responses, but smaller cholinergic currents (reduced by ~40%) in GACh2.0-expressing neurons compared to the first ACh puff ( Fig. 3b,g,h) , due presumably to the desensitization of endogenous receptors 3 . There was no difference in the amplitude, latency, or SNR of cholinergic currents in GACh2.0-expressing and non-expressing neurons ( Fig. 3b-f ), further confirming that expression of GACh2.0 had little non-specific effect on CA3 neurons.
GACh sensors in acute brain slices
We next imaged the fluorescence response of GACh2.0 in acute slices of distinct neuronal preparations, including layer 2 (L2) stellate neurons and L1 interneurons in the medial entorhinal cortex (MEC), L5 pyramidal neurons in the barrel cortex of mice, GABAergic thalamic reticular neurons, and glutamatergic thalamocortical neurons in the ventral basal nucleus of rats. Approximately 18 h after in vivo Sindbis viral expression and acute slice preparation, we measured ∆F/F 0 responses to a brief puff application of ACh ( Supplementary  Fig. 14a ). ACh and oxotremorine, but not nicotine or control bath solution ACSF, evoked robust fluorescence increases in GACh2.0expressing neurons in all the preparations (Supplementary Fig. 14) .
To further test whether GACh2.0 can report endogenously released ACh, we measured ∆F/F 0 responses of GACh2.0-expressing entorhinal L2 stellate neurons to electrical stimulation of MEC L1 (Fig. 4a) , a layer that is densely innervated by cholinergic fibers originating from the basal forebrain 28, 29 . In GACh2.0-expressing neurons, 20 pulses at 2-Hz evoked robust fluorescence responses in GACh2.0-expressing neurons ( Fig. 4b and Supplementary Movie 5), and repeated electrical stimuli delivered every 8 min induced the same ∆F/F 0 responses in GACh2.0-expressing neurons ( Fig. 4c,d) , indicating the suitability of GACh2.0 in monitoring ACh signals over long periods. Systematically varying the stimulation frequency revealed that low-frequency stimuli (0.5−2 Hz) evoked large, plateau-like fluorescence responses, intermediate-frequency stimuli (4−12 Hz) elicited more rapidly rising but briefer fluorescence responses, while high-frequency stimuli (≥32 Hz) induced minor fluorescence responses ( Fig. 4e-g) . Given that basal forebrain cholinergic neurons in behaving animals prefer low frequency (~0.5−2 Hz) tonic firing and theta rhythmic (~4−12 Hz) phasic firing 30, 31 , these results suggest that these two preferred firing patterns generate distinct sustained or transient ACh release. Further altering the number of electrical pulses delivered at 2 Hz showed that single pulses elicited detectable ∆F/F 0 responses, whereas multiple pulses induced enhanced ∆F/F 0 responses ( Fig. 4h-j ), suggesting the possible scaling of amount of released ACh by the number of presynaptic action potentials. Of note, adding 20 µM (5R,6R)6-(3propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclooctane (PTAC), an antagonist of M 1,3,5 Rs 32 , to the bath solution blocked the electrically evoked ∆F/F 0 responses ( Supplementary Fig. 15 ), indicating the detection of cholinergic signals.
We noted that at times, the minimal electrical-stimulation-evoked fluorescence responses exhibited obvious spatial heterogeneity across subcellular regions of GACh2.0-expressing L2 stellate neurons. Analysis of the evoked fluorescence responses revealed one or a few subcellular hot spots, or regions of interest (ROIs), with the largest ∆F/F 0 responses, whereas other ROIs had smaller or undetectable changes in ∆F/F 0 ( Fig. 4l-n ), suggesting the spatially restricted release and clearance of ACh. Plotting ∆F/F 0 responses at all ROIs against the distance from the ROI with the largest ∆F/F 0 responses yielded a volume transmission spread-length constant of 9.0 µm for MEC L2 stellate neurons ( Fig. 4n) . To verify this surprisingly small cholinergic volume transmission, we examined the minimal electrical-stimulation-evoked local fluorescence responses along the somatodendritic axis of GACh2.0-expressing hippocampal CA1 neurons ( Supplementary Fig. 16a ). Consistent with previous studies 27 , we found that electrical stimuli of the stratum-oriens and pyramidale were most likely to elicit cholinergic responses in CA1 neurons (Supplementary Fig. 16b,c) . The largest fluorescence responses were typically observed at one or a few subcellular ROIs in the soma of GACh2.0-expressing neurons, whereas fluorescence responses at other ROIs in the soma and dendrite of the same neurons were much smaller or undetectable (Supplementary Fig. 16b,c) . Similar analysis gave a volume transmission spread-length constant of 15.6 µm for CA1 neurons (Supplementary Fig. 16d ). Bath application of ACh, as a control, induced similar ∆F/F 0 responses along the somatodendritic axis of GACh2.0-expressing CA1 neurons ( Supplementary Fig. 16e) , ruling out the non-specific effect of unequal expression.
To determine whether GACh sensors may report other ACh release modes, we studied neurons in the medial habenula (MHb), which potentially release ACh during high-frequency firing 8, 33 . GACh2.0 sensors were successfully expressed in interpeduncular nucleus (IPN) by adenoassociated virus (AAV), and in close proximity with MHb cholinergic fibers, verified by post hoc ChAT immunostaining ( Supplementary  Fig. 17a-c) . Two-photon imaging of GACh2.0-expressing neurons showed that brief 1-, 10-, 20-, or 50-Hz 5-s electrical stimuli evoked no detectable fluorescence changes, whereas 100-Hz stimuli elicited small ∆F/F 0 responses ( Supplementary Fig. 17e,g) . Bath application of GABA or GABA B receptor agonist baclofen enhanced ∆F/F 0 responses in a frequency-dependent manner, consistent with our previous finding 33 . In contrast, saclofen, a GABA B receptor antagonist, reversed the potentiation effect. Moreover, Tio application completely abolished the ∆F/F 0 responses, while donepezil, an acetylcholinesterase inhibitor 34 , prolonged the potentiated ∆F/F 0 responses (Supplementary Fig. 17d,f,h-k) . These findings support the notion that extracellular GABA in IPN can drive habenula neuron firing in the physiological frequency range (up to 10−25 Hz 35 ) to release ACh, which may be critical for fear control 33 .
To rule out any non-specific effects that might be caused by long-term in vivo expression, we made chronic AAV expression of GACh2.0 in the dentate gyrus of hippocampus and examined the high K + -evoked calcium responses with Cal590. High K + elicited the same Cal590 fluorescence responses, compared to control non-expressing neurons (Supplementary Fig. 18 ), suggesting no non-specific effect from chronic GACh2.0 expression. Moreover, we made acute cortical slices after chronic in vivo lentiviral expression of GACh2.0 in barrel cortical L5 pyramidal neurons in mice. Simultaneous patch-clamp recordings showed that GACh2.0-expressing and control non-expressing L5 pyramidal neurons displayed the same resting membrane potential, input resistance, membrane time constant, and average spiking frequency, as well as AMPA, NMDA, and GABAergic responses, and paired pulse facilitation of AMPA responses (Supplementary Fig. 19 ).
We further examined the feasibility of optogenetic activation and optical imaging of cholinergic transmission simultaneously. We expressed DIO-oChIEF-tdTomato AAV in the basal forebrain of ChAT-Cre mice for 3 weeks, followed by Sindbis viral expression of GACh2.0 in MEC L2 stellate neurons for 18 h before preparing acute entorhinal cortical slices. We used single-photon LCD pulses (470 nm) to optogenetically stimulate oChIEF-expressing cholinergic fibers in MEC, and simultaneously used two-photon laser scanning (950 nm), which is insufficient to activate oChIEF-expressing fibers 36 , to image fluorescence responses in GACh2.0-expressing stellate neurons in MEC (Supplementary Fig. 20a ). Twenty 5-ms laser pulses (at 1 Hz) elicited consistent fluorescence responses in GACh2.0-expressing neurons, which were largely blocked by bath application of 20 µM PTAC (Supplementary Fig. 20b,c) .
GACh sensors in non-neuronal tissues
ACh released from parasympathetic nerve terminals in the pancreas and adrenal is critical for insulin secretion 37 and regulation of stress and blood pressure 38 , respectively. We made Sindbis viral expression of GACh2.0 in the mouse pancreas and adrenal in vivo, and imaged fluorescence responses of GACh2.0-expressing cells in acutely prepared pancreas and adrenal gland tissue slices ( Supplementary Figs. 21 and  22) . Single electrical stimulations of local parasympathetic cholinergic fibers evoked evident fluorescence responses in GACh2.0-expressing pancreatic and adrenal cells (Supplementary Figs. 21b,c and 22b,c and Supplementary Movies 6 and 7) . Increasing the number of stimulation pulses delivered at 2 Hz progressively increased the amplitude of ∆F/F 0 responses in pancreatic cells, while the responses plateaued with over ten pulses in adrenal cells (Supplementary Figs. 21d,e and  22d,e ). Bath application of 20 µM PTAC blocked ∆F/F 0 responses in GACh2.0-expressing pancreatic and adrenal cells ( Supplementary  Figs. 21f,g and 22f,g) , confirming the cholinergic signals.
GACh sensors in transgenic Drosophila in vivo
Next, we tested whether GACh sensors detect cholinergic transmission in live Drosophila. We created UAS-GACh1.0 and UAS-GACh2.0 transgenic flies, and crossed them with a GH146-Gal4 driver line 39 to selectively express GACh1.0 and GACh2.0 in antennal lobe projection neurons, which receive abundant cholinergic inputs from olfactory receptor neurons 40 . Two-photon imaging revealed that application of the odorant isoamyl acetate (IA) induced region-specific and dosedependent ∆F/F 0 responses in DM2 glomerulus, but not DA1 glomerulus 41, 42 (Fig. 5a-e) . Application of the odor solvent, mineral oil alone did not evoke ∆F/F 0 changes in transgenic flies (Fig. 5b,c) . As expected, IA-evoked ∆F/F 0 responses in GACh2.0 transgenic flies were about twofold larger than those in GACh1.0 transgenic flies (Fig. 5d,e) . Similarly, another odorant benzaldehyde also evoked region-specific and dosedependent ∆F/F 0 responses in the antennal lobe ( Supplementary  Fig. 23a-d) . Moreover, IA elicited ∆F/F 0 responses in the lateral horn, Fig. 23e-g) . Using the spectrum non-overlapping red Ca 2+ indicator RGECO 43 (Supplementary Fig. 24 ), again ruling out the non-specific effect from GACh expression.
GACh sensors in mouse visual cortex in vivo
Finally, we tested the performance of GACh sensors by two-photon imaging in awake mouse L2/3 visual cortex 44 (Fig. 6a) . We used a video monitor to deliver a visual stimulation consisting of 10-s images of expanding white-filled circles, which was designed to elicit both attentional and visual responses ideal to trigger ACh release in vivo [45] [46] [47] [48] . The 10-s visual stimulation, but not the following 50-s darkness, reliably induced sustained fluorescence responses in some GACh-expressing neurons (Fig. 6b-d) . However, some nearby expressing neurons exhibited no fluorescence responses to the same visual stimulation (Fig. 6b,c) , suggesting a possible spatially specific visual-stimulation-evoked ACh release in vivo ( Fig. 5 and  Supplementary Fig. 16 ).
DISCUSSION
In this study, we have developed and validated a family of genetically encoded fluorescent ACh probes, GACh sensors. GACh sensors have the sensitivity, ligand specificity, SNR, kinetics, and photostability suitable for monitoring cholinergic signals in diverse tissue preparations in vitro, ex vivo, and in vivo. As with GCaMP3 (ref. 49 ) and iGluSnFR 50 , the ∆F/F 0 responses of GACh sensors in intact tissues are smaller than in cultured cells, presumably attributable to the higher tissue background/basal fluorescence. We also noted that GACh sensors have a weak coupling to downstream G-protein intracellular signaling in cultured cells, yet this coupling has no detectable effect on basic membrane properties, synaptic properties, and cholinergic transmission in rodent neurons in vitro and in vivo, as well as sensory input-evoked cholinergic responses in Drosophila in vivo.
Central cholinergic neurons exhibit multiple distinct action-potential firing patterns 30, 31, 35 , yet the functional significance of these firing patterns remains elusive. Here we report that basal forebrain cholinergic neurons use low frequency 0.5−2 Hz tonic firing to generate large plateau-like postsynaptic ACh signals, and 8−12 Hz theta rhythmic phasic firing to elicit small transient postsynaptic ACh signals. A possible explanation is that the high-frequency activation of cholinergic fibers may be more effective in recruiting presynaptic auto-receptor inhibition mechanisms to suppress ACh release 51 , which yield more transient ACh signals. On the other hand, habenula neurons can fire high-frequency action potentials of up to 10−25 Hz 35 . The firing triggers co-release of ACh with its primary neurotransmitter glutamate when a presynaptic GABA B R-mediated potentiation mechanism is engaged. Although detailed aspects of cholinergic regulations remain to be worked out, our data are consistent with the view that presynaptic regulatory mechanisms may play key roles in governing release modes in central cholinergic transmission.
Another unresolved question concerns cholinergic volume transmission; whether ACh acts globally affecting a large number of neurons or mediates spatially restricted volume transmission remains a matter of debate [1] [2] [3] 13 . Directly visualizing the spread of released ACh in the hippocampus and MEC has allowed us to estimate the spread length constant of central cholinergic transmission, which ranges ~9-15 µm. Because the minimal electrical stimulation may activate multiple ACh release sites, this value is likely to be overestimated. Nevertheless, the estimation provides the first suggestion that central cholinergic transmission may have single-cell or subcellular specificity. Since G-protein-coupled receptors may relay postsynaptic signaling in a highly spatially restricted manner 52 , it is tempting to speculate that intercellular cholinergic signal communication can achieve subcellular precision. Together, the findings of fine firingfrequency-controlled release and spatially restricted volume transmission advance our fundamental understanding of the regulation and precision of cholinergic signaling.
GACh sensors, which allow visualization of ACh signals in animal models ex vivo and in vivo, should advance our understanding of the pathogenesis of various diseases. For example, cholinergic signals are essential for high-level cognitive functions, including learning and The fluorescence response traces were divided into 10 s segments with every minute containing one 10-s trace corresponding to the period of visual stimulus and five 10-s traces corresponding to periods of darkness. The signal from the middle three dark segments (black line) was compared to the signal from the visual stimulus segments (blue line; 15 trials per region). Shaded bands around the solid blue trace show the 95% confidence interval obtained by bootstrap. Note that ROI #1, but not ROI #2, shows an increase in fluorescence responses to the visual stimulus. (e) Average fluorescence responses obtained during the period of visual stimulation compared to those during the period of darkness (visual: 3.37 ± 2.26%; dark: 0.05 ± 0.83%; Z = -2.666, P = 0.008; n = 9 neurons from eight animals). Note the same ACh signals observed after 1 d (n = 5 neurons from four animals), 2 d (n = 2 neurons from two animals), and 4-6 d (n = 2 neurons from two animals) in vivo Sindbis or rapid AAV viral expression, which suggest the suitability of GACh sensors for multiple-day imaging, and the analysis made from the pooled data. Data are shown as mean ± s.e.m.; shaded bands indicate s.e.m. Wilcoxon tests performed in e, two-sided. memory, and dysregulation of cholinergic transmission is linked with various neurological disorders, including Alzheimer's disease. Yet, the cholinergic hypothesis-based acetylcholinesterase inhibitor treatment, the only available therapy for Alzheimer's disease 53 , has limited efficacy and is far from ideal 34, 54 . Further understanding of central cholinergic transmission in physiological and pathological conditions is central to development of effective therapeutic strategies for Alzheimer's disease and other neurological diseases. Moreover, defective cholinergic signals have been implicated in the pathophysiology and treatment of a number of other non-neurological diseases [5] [6] [7] , including diabetes 37 , cardiovascular diseases 38 , inflammation 55 , and tumorigenesis 56 . We show here that GACh sensors are effective in monitoring cholinergic transmission in non-neuronal cells as well, including cells of the pancreas and adrenal, thus endorsing the use of this tool to unravel the cholinergic mechanisms underlying these pathological conditions.
METhODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
Fluorescence imaging of cultured cells and neurons. In some experiments, the fluorescence signals of HEK293T cells transfected with the muscarinic receptor-based chimeric constructs were measured with a TECAN Safire2 fluorescence plate reader (TECAN, Männedorf, Switzerland; excitation, 480 nm; emission, 520 nm). During the measurement, the culture media was replaced with 100 µl Tyrode solution containing ACh at varied concentrations from 0-100 µM. The ∆F/F 0 of each construct was obtained by averaging the AChinduced fluorescence responses of transfected wells after digitally subtracting that of neighboring control non-transfected wells.
In other culture cell experiments, HEK293T cells and cultured neurons were imaged by an inverted Nikon Ti-E A1 confocal microscope with a 40 × /1.35 NA oil objective (Nikon, Tokyo, Japan). Cells were perfused with standard extracellular Tyrode solution containing (in mM): 150 NaCl, 4 KCl, 2 MgCl 2 , 2 CaCl 2 , 10 HEPES and 10 Glucose, with pH of 7.4, in an imaging chamber during imaging. Agonist acetylcholine (Solarbio, Beijing, China), tiotropium bromide (Dexinjia Bio & Tech Co., Ltd, Jinan, China), and AF-DX 384 (Sigma-Aldrich) were delivered with a custom-made perfusion system and/or bath applied. The chamber was washed with Tyrode solution between applications and cleaned with 75% ethanol between experiments.
Fluorescence imaging of cells in cultured and acute slice preparations.
Wide-field epifluorescence imaging was performed using Hamamatsu ORCA FLASH4.0 camera (Hamamatsu Photonics, Japan), and GACh-expressing cells in cultured hippocampal slices and acutely prepared brain slices are excited by a 460-nm ultrahigh-power low-noise LED (Prizmatix, Givat-Shmuel, Israel). The frame rate of FLASH4.0 camera was set to 10 Hz. To synchronize image capture with drug perfusion, electrical stimulation, and/or electrophysiological recording, the camera was set to external trigger mode and triggered by a custom-written IGOR Pro 6 program (WaveMetrics, Lake Oswego, OR). Agonists or antagonists, including acetylcholine and atropine (Sigma-Aldrich), and nicotine, oxotremorine M, PTAC and TMPH (Tocris Bioscience, Bristol, UK), were either bath-applied or puff-applied with a glass pipette (~1 µm in tip diameter) positioned ~150 µm above the imaged neurons using 500-ms 30-kPa pressure pulses.
Two-photon imaging was performed using a custom-built microscope or an Olympus FV1000 microscope (for IPN experiments; Olympus, Japan). The parameters of frame scan were typically set at a size of 200 × 200 pixels and a speed of 1 frame/s. For all optical experiments, the actual two-photon scanning time was set at ~700 ms/frame, and 20 10-ms 470-nm blue M470F1 LED (Thorlabs, NJ) light pulses were synchronously delivered at 1 Hz during the ~300-ms frame scanning break periods to activate oChIEF-tdTomato expressing cholinergic fibers without interfering two-photon imaging. The blue light of the LED was fiber-coupled to an Ø200 µm fiber optic cannula positioned ~250 µm away from imaged neurons. The light power out of the cannula was set at 2 mW. The fluorescence of GACh2.0 was excited by a femtosecond Ti:Sapphire laser (Chameleon Ultra II, Coherent) at a wavelength of 950 nm. Changes in fluorescence were quantified as increases in fluorescence from baseline divided by resting fluorescence (∆F/F 0 ) and averaged for ~10 trials. To quantify surface expression of GACh sensors, lentiviral expression of GACh1.0, GACh1.5, or GACh2.0 was made in the CA1 region of organotypic hippocampal cultured slices. About ~1−2 weeks after expression, GACh-expressing CA1 pyramidal neurons were patch-clamp recorded and loaded with 25 µM Alexa Fluor 594 (Life Technologies) for ~10 min, and two-photon images were then taken at different compartments along the apical dendrites. The multiple patch-clamp recordings, optogenetics, epifluorescence, and two-photon imaging were typically operated by a single custom-written IGOR Pro 6 program (WaveMetrics, Lake Oswego, OR). To image the high KCl-induced calcium signals, 20 µM Cal590F (AAT Bioquest Inc., Sunnyvale, CA) was bath-loaded into hippocampal cells in acute slices and subsequently washed with ACSF for 30 min before imaging. Cal590 dye was excited with a two-photon laser at 950 nm, and 90 mM KCl was perfused to stimulate calcium signals.
immunocytochemistry. Mice infected with GACh sensors were deeply anesthetized with pentobarbital (400 mg/kg; i.p.), and transcardially perfused first with cold normal saline and then 4% paraformaldehyde in 0.1 M PBS. Brain blocks were post-fixed for ≥4 h, cryoprotected in 30% sucrose for ≥24 h, then embedded in tissue freezing medium and sectioned into 50-µm-thick coronal sections with a freezing Leica CM 1900 microtome (Leica, Germany). To label cholinergic terminals from MHb-and GACh-expressing neurons in IPN, tissue sections were rinsed and immunoreacted with goat ChAT antibody (1:500, Millipore, #ab144p) and rabbit GFP antibody (1:500, Abcam, #ab6556), and then labeled with goat-anti-rabbit second antibody conjugated Alexa 488 and donkey-anti-goat second antibody conjugated Alexa 555 after extensive washing. The immunolabeled tissue sections were imaged with a confocal microscope.
To recover the morphology of recorded neurons, the slices were fixed by immersion in 3% acrolein/4% paraformaldehyde in 0.1 M PBS at 4 °C for 24 h after in vitro patch-clamp recordings with internal solution containing additional 1% biocytin, and then processed with the avidin-biotin-peroxidase method to reveal cell morphology. The morphologically recovered cells were examined and reconstructed with the aid of a microscope equipped with a computerized reconstruction system Neurolucida (MicroBrightField, Colchester, VT).
Fluorescence imaging of transgenic Drosophila. Transgenic Drosophila lines with strong GACh expression levels and robust odor responses were chosen after crossing UAS-GACh1.0 and UAS-GACh2.0 transgenic flies with a GH146-Gal4 driver line. They were reared at room temperature for 8~12 d on standard medium after eclosion before experiments. For imaging experiments, live flies were mounted and prepared as in our previous study 69 . Briefly, animals were mounted to a small dish, with their rectangular patch of cuticle between the eyes, excessive fat bodies and air sacs surrounding the antennal lobe removed, and the pair of muscles underneath the proboscis cut to reduce the brain movement. Isoamyl acetate (Sigma-Aldrich; Cat# 306967) and benzaldehyde (Sinopharm Chemical Reagent Co., Ltd., Shanghai, China, Cat# 30017018) were initially diluted by 100-fold or 1000-fold (vol/vol) in mineral oil (Sigma-Aldrich; Cat# 69794) and then placed in a glass bottle (100 µl in 900 µl mineral oil), delivered at 200 ml/min, and mixed with purified air (1000 ml/min). The mixed air stream was presented to flies through a 1-cm-wide opening Teflon tube placed ~1 cm from their antennas, and controlled by Teflon solenoid valves and synchronized with the image acquisition system by Arduino boards. Imaging was made using a commercial Olympus BX61WI two-photon microscope with a 25 × /NA: 1.05 water-immersion objective and a modelocked Ti:Sapphirelaser (Mai tai) tuned to 950 nm. The Glomeruli were identified according to the previous established antennal lobe map 70 .
Fluorescence imaging of behaving mice. Mice were initially anesthetized to remove the head skin to attach a metal recording chamber, followed by a 3−5-day recovery and another 2−5-day head-fixation habituation. The animals were then anesthetized again to open the skull above the primary visual cortex (centered ~2.5 lateral, ~1.5 mm anterior from lambda) to pressure inject ~100 nl of Sindbis virus of GACh2.0 or AAV viruses of hsyn-tTA and TRE-GACh2.0 (with a 1:1 mix ratio; a speeded AAV expression approach 71 ). The craniotomy was completed by fitting a cranial window made with a 3-mm circular or a 2 × 2 mm square #2 coverslip. About 16 h after the surgery, the animals were head-fixed on a circular treadmill and imaged using a custom-built 2-photon system powered with an InSight DS+ laser (Spectra Physics) and operated with ScanImage 5.1 software 72 . Images were acquired from individual cells (or small groups of cells when possible) continuously at either 30 Hz (512 × 512 pixels) or 60 Hz (256 × 256 pixels). The mouse was shown a stimulus consisting of 50 s of darkness followed by 10 s of expanding white circles appearing at random positions on the screen. All data analysis was done in Matlab (Mathworks). Automatic image alignment was validated by manual inspection. ROIs were manually drawn over the cell bodies and raw fluorescent traces were extracted. Fluorescent traces were filtered by a 2 s moving average window to reduce fluctuations, and divided into 10 s segments corresponding to either periods of darkness or periods of visual stimulation, and the maximum ∆F/F 0 was compared for periods with or without stimulation.
Statistical analysis.
Statistical results were reported as mean ± s.e.m. The signalto-noise ratio (SNR) was calculated as the peak response dividing the standard error of baseline fluorescence. Animals were randomly assigned into control or experimental groups and investigators were blinded to experiment treatments.
Given the negative correlation between the variation and square root of sample number, n, the group sample size was typically set to be ~10-25 to optimize the power of statistical tests and efficiency. Statistical significance of the means (P < 0.05; two sides) were determined using Wilcoxon and Mann-Whitney Rank Sum non-parametric tests for paired and unpaired samples, respectively. Statistical significances of the linear relationships of two data groups were determined using linear regression t tests provided the normality and constant variance tests passed.
Life Sciences reporting Summary. Further information on experimental design is available in the Nature Research Reporting Summary linked to this article.
Data availability. The plasmid pDisplay-GACh2.0 (#106073) has been deposited to the Addgene database (deposit #74965). Corresponding author(s): Yulong Li
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Experimental design 1. Sample size
Describe how sample size was determined.
No statistical methods were used to pre-determine sample sizes, but given the negative correlation between the variation and square root of sample number, n, the group sample size was typically set to be ~10-25 to optimize the power of statistical tests and efficiency.
Data exclusions
Describe any data exclusions.
No data was excluded from the analysis.
Replication
Describe whether the experimental findings were reliably reproduced.
Each data in this manuscript is reliably reproduced. The replication number of each data is indicated in the legend of corresponding figures.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Animals or cells were randomly assigned into control or experimental groups.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
No blinding was carried out in sensor development and characterizations in cultured cells, which refer to data in Fig. 1-2 . For slice and in vivo experiments in Fig. 3-8 , investigators were blinded to the group allocation during the experiment.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
